Epileptic drug treatment during pregnancy
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Gurevich, Ravit | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztály | hu_HU |
| dc.date.accessioned | 2020-02-27T10:11:10Z | |
| dc.date.available | 2020-02-27T10:11:10Z | |
| dc.date.created | 2019-04-05 | |
| dc.description.abstract | Epileptic drug treatment during pregnancy is a complexed,requiring a close observation on these women prior conception, throughout pregnancy as well as in the postpartum period in which the newborns can be found to have malformations as a result of antiepileptic drug exposure in-utero. The aim is to acheive good seizure control in the mother with the a drug which has the best safety profile with least possible teratogenic effects. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 42 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/281286 | |
| dc.language.iso | en | hu_HU |
| dc.subject | epilepsy | hu_HU |
| dc.subject | pregnancy | hu_HU |
| dc.subject | teratogenicity | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Epileptic drug treatment during pregnancy | hu_HU |